Skip to content
Search

Latest Stories

Nearly 1 in 6 pharmacies may close within the next year, CPE report warns

Nearly 1 in 6 pharmacies may close within the next year, CPE report warns

Many pharmacies are struggling to stay afloat due to spiralling costs, increased workload and a 30% funding cut in real terms since 2015

A new report from Community Pharmacy England (CPE) has raised alarms about the severe financial challenges plaguing pharmacies across the sector, threatening their ability to provide even the core services for their patients.


The findings are based on responses from over 6,100 pharmacy owners and 2,000 pharmacy staff who participated in the recent Pharmacy Pressures Survey 2024.

The report reveals that spiralling costs and increased workloads, coupled with a 30 per cent funding cut in real terms since 2015, are putting countless pharmacies at risk of closure.

“Nearly 1 in 6 may close within the next year,” the report revealed.

A vast majority (94 per cent) of pharmacy owners reported that they have seen significant increases in costs, with almost two-thirds (64 per cent) saying they are operating at a loss.

Concerningly, these financial pressures are now affecting patient care, as 18 per cent of pharmacy staff reported severe impacts.

The survey revealed that most pharmacies are experiencing longer prescription dispensing times (86 per cent), delays in responding to patient inquiries (80 per cent), and less time to spend with patients (79 per cent).

In a CPE survey conducted earlier this year, more than 40 per cent of the pharmacy owners noted that the financial strain is limiting their ability to provide Advanced services.

This concern was further supported by a June snap poll, where nearly a third of pharmacies reported discontinuing some of these services.

Recognising the sector's crisis, Community Pharmacy England is urging immediate action to address the financial challenges facing pharmacies, secure their future and protect the health of local communities across England.

Janet Morrison, Chief Executive of CPE, emphasised the urgency of the situation:

“Community pharmacies are under severe financial strain, with widespread profitability concerns. Many are losing money and uncertain about their ability to survive another year: this is a direct consequence of the significant funding cuts and spiralling costs which have pushed them to the brink.

“Our findings make distressing reading, and they should be ringing alarm bells for anybody interested in protecting the health and wellbeing of local communities and the public.

“We’ve been warning for many months and years that these issues must be resolved, and this evidence provides yet another stark warning which must not be ignored.”

Pharmacy owners and Local Pharmaceutical Committees (LPCs) are being encouraged to use the current break in Parliamentary activity to engage with local MPs and seek their support for the pharmacy sector.

This report is part of a series being developed to explore the findings of the 2024 Pharmacy Pressures Survey.

 

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less